Lupin Irbesartan Tablets Recalled for Impurity Contamination
Lupin Pharmaceuticals is recalling Irbesartan 75 mg tablets due to detection of the impurity N-nitrosoirbesartan in the active pharmaceutical ingredient. The recall affects 51,144 bottles distributed nationwide.
- Product
- IRBESARTAN — IRBESARTAN (IRBESARTAN)
- Category
- Drug
- Distribution
- Distributed nationwide